Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Siegfried Gallistl

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Clinical Laboratory|March 6, 2004
A laboratory method for parallel determination of platelet aggregation and thrombin generationMartin Köstenberger, Siegfried Gallistl, Gerhard Cvirn, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|December 23, 2004
Drotrecogin alfa activated (recombinant human activated protein C) in combination with heparin or melagatran: effects on prothrombin time and activated partial thromboplastin timeMartin Koestenberger, Gerhard Cvirn, Siegfried Gallistl, et al.
Journal of Pediatric Endocrinology & Metabolism : JPEM|January 13, 2004
Rewarming index of the lower leg assessed by infrared thermography in adolescents with type 1 diabetes mellitusHeinz Zotter, Reinhold Kerbl, Siegfried Gallistl, et al.
Journal of Pediatric Endocrinology & Metabolism : JPEM|August 11, 2004
Effects of TRH administration on plasma leptin levels in infants, children and adolescentsHeinz Zotter, Siegfried Gallistl, Reinhold Kerbl, et al.
Acta Paediatrica (Oslo, Norway : 1992)|September 29, 2005
Recombinant human activated protein C, heparin and melagatran in umbilical cord versus adult plasmaMartin Koestenberger, Gerhard Cvirn, Siegfried Gallistl, et al.
Journal of Pharmaceutical and Biomedical Analysis|August 14, 2016
Non-enzymatic quantification of polyphosphate levels in platelet lysates and releasatesAxel Schlagenhauf, Sina Pohl, Harald Haidl, et al.
Metabolism: Clinical and Experimental|July 1, 2005
Leptin responses to insulin administration in children with short statureHeinz Zotter, Reinhold Kerbl, Siegfried Gallistl, et al.
Journal of Thrombosis and Thrombolysis|March 4, 2005
Drotrecogin alfa (activated, Xigris) in combination with heparin or melagatran: an in vitro investigationMartin Koestenberger, Gerhard Cvirn, Siegfried Gallistl, et al.
Thrombosis Research|November 30, 2004
Anticoagulant action of melagatran, the active form of the oral direct thrombin inhibitor ximelagatran, in umbilical cord and adult plasma: an in vitro examinationMartin Koestenberger, Siegfried Gallistl, Gerhard Cvirn, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|November 15, 2006
Effects of melagatran on activated partial thromboplastin time and on ecarin clotting time in cord versus adult plasmaMartin Koestenberger, Siegfried Gallistl, Leschnik Bettina, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Clinical Laboratory|March 6, 2004
A laboratory method for parallel determination of platelet aggregation and thrombin generationMartin Köstenberger, Siegfried Gallistl, Gerhard Cvirn, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|December 23, 2004
Drotrecogin alfa activated (recombinant human activated protein C) in combination with heparin or melagatran: effects on prothrombin time and activated partial thromboplastin timeMartin Koestenberger, Gerhard Cvirn, Siegfried Gallistl, et al.
Journal of Pediatric Endocrinology & Metabolism : JPEM|January 13, 2004
Rewarming index of the lower leg assessed by infrared thermography in adolescents with type 1 diabetes mellitusHeinz Zotter, Reinhold Kerbl, Siegfried Gallistl, et al.
Journal of Pediatric Endocrinology & Metabolism : JPEM|August 11, 2004
Effects of TRH administration on plasma leptin levels in infants, children and adolescentsHeinz Zotter, Siegfried Gallistl, Reinhold Kerbl, et al.
Acta Paediatrica (Oslo, Norway : 1992)|September 29, 2005
Recombinant human activated protein C, heparin and melagatran in umbilical cord versus adult plasmaMartin Koestenberger, Gerhard Cvirn, Siegfried Gallistl, et al.
Journal of Pharmaceutical and Biomedical Analysis|August 14, 2016
Non-enzymatic quantification of polyphosphate levels in platelet lysates and releasatesAxel Schlagenhauf, Sina Pohl, Harald Haidl, et al.
Metabolism: Clinical and Experimental|July 1, 2005
Leptin responses to insulin administration in children with short statureHeinz Zotter, Reinhold Kerbl, Siegfried Gallistl, et al.
Journal of Thrombosis and Thrombolysis|March 4, 2005
Drotrecogin alfa (activated, Xigris) in combination with heparin or melagatran: an in vitro investigationMartin Koestenberger, Gerhard Cvirn, Siegfried Gallistl, et al.
Thrombosis Research|November 30, 2004
Anticoagulant action of melagatran, the active form of the oral direct thrombin inhibitor ximelagatran, in umbilical cord and adult plasma: an in vitro examinationMartin Koestenberger, Siegfried Gallistl, Gerhard Cvirn, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|November 15, 2006
Effects of melagatran on activated partial thromboplastin time and on ecarin clotting time in cord versus adult plasmaMartin Koestenberger, Siegfried Gallistl, Leschnik Bettina, et al.
Pageof 4